Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
Alternative splicing is a well-studied gene regulatory mechanism that produces biological diversity by allowing the production of multiple protein isoforms from a single gene. An involvement of alternative splicing in the key biological signalling Hippo pathway is emerging and offers new therapeutic...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-03-01
|
Series: | Genes |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4425/9/3/161 |
id |
doaj-c75de1b1b17c4d2fa4fdc22869762929 |
---|---|
record_format |
Article |
spelling |
doaj-c75de1b1b17c4d2fa4fdc228697629292020-11-24T21:04:47ZengMDPI AGGenes2073-44252018-03-019316110.3390/genes9030161genes9030161Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic TargetsSean Porazinski0Michael Ladomery1Faculty of Health and Applied Sciences, University of the West of England, Frenchay Campus, Bristol BS16 1QY, UKFaculty of Health and Applied Sciences, University of the West of England, Frenchay Campus, Bristol BS16 1QY, UKAlternative splicing is a well-studied gene regulatory mechanism that produces biological diversity by allowing the production of multiple protein isoforms from a single gene. An involvement of alternative splicing in the key biological signalling Hippo pathway is emerging and offers new therapeutic avenues. This review discusses examples of alternative splicing in the Hippo pathway, how deregulation of these processes may contribute to disease and whether these processes offer new potential therapeutic targets.http://www.mdpi.com/2073-4425/9/3/161Hippo pathwayalternative splicingyes-associated proteinsplice-switching oligonucleotidesgene therapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sean Porazinski Michael Ladomery |
spellingShingle |
Sean Porazinski Michael Ladomery Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets Genes Hippo pathway alternative splicing yes-associated protein splice-switching oligonucleotides gene therapy |
author_facet |
Sean Porazinski Michael Ladomery |
author_sort |
Sean Porazinski |
title |
Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets |
title_short |
Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets |
title_full |
Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets |
title_fullStr |
Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets |
title_full_unstemmed |
Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets |
title_sort |
alternative splicing in the hippo pathway—implications for disease and potential therapeutic targets |
publisher |
MDPI AG |
series |
Genes |
issn |
2073-4425 |
publishDate |
2018-03-01 |
description |
Alternative splicing is a well-studied gene regulatory mechanism that produces biological diversity by allowing the production of multiple protein isoforms from a single gene. An involvement of alternative splicing in the key biological signalling Hippo pathway is emerging and offers new therapeutic avenues. This review discusses examples of alternative splicing in the Hippo pathway, how deregulation of these processes may contribute to disease and whether these processes offer new potential therapeutic targets. |
topic |
Hippo pathway alternative splicing yes-associated protein splice-switching oligonucleotides gene therapy |
url |
http://www.mdpi.com/2073-4425/9/3/161 |
work_keys_str_mv |
AT seanporazinski alternativesplicinginthehippopathwayimplicationsfordiseaseandpotentialtherapeutictargets AT michaelladomery alternativesplicinginthehippopathwayimplicationsfordiseaseandpotentialtherapeutictargets |
_version_ |
1716769757934387200 |